[CIS PIDD] [cis-pidd] CVID patient with agranulocytosis

[Christine M. Seroogy, MD]

Dear Colleagues,

I am seeking advice on alternative therapies for a 20 y/o CVID patient with severe autoimmune neutropenia.

He presented 8 years ago with autoimmune hemolytic anemia and met criteria for CVID.  He was in good health on SQIG until Sept. of this year when his neutrophil count started to drop.  This was initially attributed to medication side effect (abilify started in Feb 2013 for bipolar disease).  The medication was stopped without improvement in his neutrophil count.  He was given neulasta with brief increase in neutrophil count.  He was hospitalized at an outside facility with fever and neutropenia in Oct 2013.  Bone marrow biopsy showed decreased granulocytic precursors, lymphoid aggregates (CD4+).  He was treated with prednisone and high-dose IVIG without response.  Unfortunately, he developed a surgical abdomen and was found to have a ruptured appendix.  This was medically managed.  He was subsequently hospitalized at our facility (mid Nov 2013).  Pertinent data:


  1.  Continued medical management of ruptured appendix with surgically placed drain after wash-out. Growing two species MDR Pseudomonas, VRE, along with scant Candida.
  2.  Status-post 4 doses of rituxan with last dose 2 weeks ago.
  3.  Cellcept 600mg/m2/dose IV for 2 weeks
  4.  Repeat bone marrow last week with essentially absent granulocytic/monocytic precursors and persistence of lymphoid aggregates, paucity of B cells. Other lineages are normal.
  5.  Receiving WBC transfusions daily for 2 weeks.
  6.  Infectious work-up (EBV, HIV, adeno, CMV) negative. Anti-neutrophil antibodies are positive.
  7.  Receiving monthly IVIG at 500 mg/kg and on 20 mg prednisone daily.

Unfortunately, his neutrophil count has not improved.  He is clinically "stable" with the present management and our surgical team will not remove his ruptured appendix with walled off abscess at this time given his poor healing risk. With his bone marrow evolving to an agranulocytosis picture, we are considering other treatment options.  One thought is to discontinue the cellcept and start cyclosporin.

Have others treated such a patient? Any thoughts on additional approaches would be appreciated.

Thank you

Chris


Christine M. Seroogy MD,  FAAAAI
Associate Professor
University of Wisconsin School of Medicine and Public Health
Department of Pediatrics
Division of Allergy, Immunology & Rheumatology
1111 Highland Avenue
4139 WIMR
Madison, WI  53705-2275
phone: 608-263-2652
fax: 608-265-9721





Confidentiality Notice: The information in this message (and the documents attached to it, if any) is confidential and may be legally privileged. It is intended solely for the addressee. Access to this message by anyone else is unauthorized. If you are not the intended recipient, any disclosure, copying, distribution or any action taken, or omitted to be taken in reliance on it is prohibited and may be unlawful. If you have received this message in error, please delete all electronic copies of this message (and the documents attached to it, if any), destroy any hard copies you may have created and notify me immediately by replying to this email. Thank you.

---
The CIS-PIDD listserv is supported by the Clinical Immunology Society
The science & practice of human immunology

P: +1.414.224.8095
E: info at clinimmsoc.org

Not a member of CIS? Please visit www.clinimmsoc.org to join!

You are currently subscribed to cis-pidd as: pagid at list.clinimmsoc.org.
To unsubscribe click here: http://lm.clinimmsoc.org/u?id=183939985.3ea13d40a15475ac00ebbd9cd8a37d6d&n=T&l=cis-pidd&o=44291154
or send a blank email to leave-44291154-183939985.3ea13d40a15475ac00ebbd9cd8a37d6d at lists.clinimmsoc.org
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://seven.pairlist.net/pipermail/pagid/attachments/20131226/ae94e52d/attachment-0001.htm>